[go: up one dir, main page]

DE60038739D1 - Somatostatin analoge, deren radiomarkierte derivate und deren verwendung - Google Patents

Somatostatin analoge, deren radiomarkierte derivate und deren verwendung

Info

Publication number
DE60038739D1
DE60038739D1 DE60038739T DE60038739T DE60038739D1 DE 60038739 D1 DE60038739 D1 DE 60038739D1 DE 60038739 T DE60038739 T DE 60038739T DE 60038739 T DE60038739 T DE 60038739T DE 60038739 D1 DE60038739 D1 DE 60038739D1
Authority
DE
Germany
Prior art keywords
somatostatin
compounds
somatostatin analogs
diagnosing
pharmacophores
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60038739T
Other languages
English (en)
Other versions
DE60038739T2 (de
Inventor
John Lister-James
Richard T Dean
Daniel A Pearson
David M Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xanthus Pharmaceuticals Inc USA
Original Assignee
Xanthus Pharmaceuticals Inc USA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xanthus Pharmaceuticals Inc USA filed Critical Xanthus Pharmaceuticals Inc USA
Publication of DE60038739D1 publication Critical patent/DE60038739D1/de
Application granted granted Critical
Publication of DE60038739T2 publication Critical patent/DE60038739T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60038739T 1999-08-27 2000-08-23 Somatostatin analoge, deren radiomarkierte derivate und deren verwendung Expired - Lifetime DE60038739T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15100199P 1999-08-27 1999-08-27
US151001P 1999-08-27
US09/397,792 US6358491B1 (en) 1999-08-27 1999-09-16 Somatostatin analogs
US397792 1999-09-16
PCT/IB2000/002072 WO2001044177A2 (en) 1999-08-27 2000-08-23 Somatostatin analogs, radiolabelled derivatives thereof and their use

Publications (2)

Publication Number Publication Date
DE60038739D1 true DE60038739D1 (de) 2008-06-12
DE60038739T2 DE60038739T2 (de) 2009-05-20

Family

ID=26848228

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60038739T Expired - Lifetime DE60038739T2 (de) 1999-08-27 2000-08-23 Somatostatin analoge, deren radiomarkierte derivate und deren verwendung

Country Status (12)

Country Link
US (1) US6358491B1 (de)
EP (1) EP1208116B1 (de)
JP (1) JP2003517037A (de)
AT (1) ATE393781T1 (de)
AU (1) AU782873B2 (de)
CA (1) CA2383936A1 (de)
CO (1) CO5460266A1 (de)
DE (1) DE60038739T2 (de)
ES (1) ES2305000T3 (de)
PE (1) PE20010516A1 (de)
TW (1) TWI243178B (de)
WO (1) WO2001044177A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69839477D1 (de) * 1997-11-24 2008-06-26 Univ Louisiana State Verfahren zum verbessern der anhäufung von radioaktiven verbindungen in gewebe
EP1283216A1 (de) * 2001-08-10 2003-02-12 Mallinckrodt Inc. Alle somatostatinrezeptorsubtypen-bindende Somatostatinanaloge und deren Verwendung
DE10215336A1 (de) * 2002-03-28 2003-10-23 Schering Ag N-Methyl-Homocysteine und ihre Verwendung sowie Verfahren zu ihrer Herstellung
AU2002359359A1 (en) * 2001-12-28 2003-07-24 Somatocor Pharmaceuticals, Inc. Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands
JP5395327B2 (ja) * 2003-09-17 2014-01-22 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 機構ベースの標的化した膵臓β細胞画像化および治療
EP1700608A1 (de) 2005-03-10 2006-09-13 Schering AG Chelate für radioaktiv markierte Konjugate mit einer stabilisierenden Seitenkette
JP2008538204A (ja) * 2005-03-10 2008-10-16 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 安定化側鎖を含む放射性標識複合体キレート剤
EP1717247A1 (de) * 2005-04-28 2006-11-02 Schering AG Zyklische Peptide, die sich am Somatostatinrezeptor binden
WO2006114324A1 (en) * 2005-04-28 2006-11-02 Schering Ag Compounds comprising cyclized somatostatin receptor binding peptides
EP1717219A1 (de) * 2005-04-28 2006-11-02 Schering AG Orthogonal geschützte bifunktionelle Aminosäure
US20070025910A1 (en) 2005-07-29 2007-02-01 Norenberg Jeffrey P Anticancer therapy
ES2351569B8 (es) * 2009-05-07 2012-06-20 Bcn Peptides S.A. Ligandos peptídicos de receptores de somatostatina.
RU2528414C1 (ru) * 2013-01-25 2014-09-20 Закрытое Акционерное Общество "Фарм-Синтез" Циклический октапептид, радиофармацевтическое средство на его основе и способ применения радиофармацевтического средства для получения лекарственных (фармацевтических) средств для лечения новообразований, экспрессирующих соматостатиновые рецепторы
EP2961765A4 (de) * 2013-03-15 2016-11-09 Adaerata Ltd Partnership Kleinmolekülige pcsk9-modulatoren und verfahren zur verwendung davon
MX379365B (es) 2014-06-30 2025-03-11 Tarveda Therapeutics Inc Conjugados y partículas direccionados y formulaciones de estos.
JP7057278B2 (ja) 2015-10-28 2022-04-19 ターベダ セラピューティクス インコーポレイテッド Ｓｓｔｒ標的化コンジュゲート及び粒子並びにその製剤
ES2960030T3 (es) 2017-01-12 2024-02-29 Radiomedix Inc Tratamiento de células cancerosas que sobreexpresan receptores de somatostatina utilizando derivados de ocreótido quelados con radioisótopos

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310518A (en) 1979-10-31 1982-01-12 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4486415A (en) 1983-08-15 1984-12-04 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4522813A (en) 1983-10-27 1985-06-11 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
EP0222578A3 (de) 1985-11-06 1990-04-04 Merck & Co. Inc. Verwendung von cyclischen Somatostatinanaloga zur Behandlung von sofortigen Überempfindlichkeitskrankheiten
US5776894A (en) 1988-12-05 1998-07-07 Novartis Ag Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors
US5985240A (en) 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
US7238340B1 (en) * 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
WO1995000553A1 (en) * 1993-06-23 1995-01-05 Diatech, Inc. Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US5932189A (en) * 1994-07-29 1999-08-03 Diatech, Inc. Cyclic peptide somatostatin analogs
GB9417873D0 (en) 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds
US5597894A (en) 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
US5770687A (en) 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
US5830431A (en) 1995-06-07 1998-11-03 Mallinckrodt Medical, Inc. Radiolabeled peptide compositions for site-specific targeting
MY147327A (en) 1995-06-29 2012-11-30 Novartis Ag Somatostatin peptides
US5708135A (en) 1995-09-29 1998-01-13 Biomeasure Incorporated Cyclic peptide analogs of somatostatin
AT405906B (de) 1997-03-14 1999-12-27 Irene Dr Virgolini Radiomarkierte somatostatin rezeptor-liganden zur diagnose und therapie

Also Published As

Publication number Publication date
EP1208116A2 (de) 2002-05-29
TWI243178B (en) 2005-11-11
ES2305000T3 (es) 2008-11-01
JP2003517037A (ja) 2003-05-20
AU4865901A (en) 2001-06-25
CO5460266A1 (es) 2004-11-30
AU782873B2 (en) 2005-09-08
CA2383936A1 (en) 2001-06-21
DE60038739T2 (de) 2009-05-20
PE20010516A1 (es) 2001-04-29
WO2001044177A3 (en) 2002-03-28
US6358491B1 (en) 2002-03-19
EP1208116B1 (de) 2008-04-30
WO2001044177A2 (en) 2001-06-21
ATE393781T1 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
DE60038739D1 (de) Somatostatin analoge, deren radiomarkierte derivate und deren verwendung
IL140622A0 (en) Biphenyl sufonamide derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
NO20022655D0 (no) <Beta>-2-adrenerge reseptoragonister
ATE480252T1 (de) Peptidantagonist von zonulin und dessen verwendung
BR0208179A (pt) Composto, composição farmacêutica, métodos para tratar distúrbios associados com o receptor 5-ht6, distúrbios cognitivos, distúrbios da mémoria, psicose, esquizofrenia, e ansiedade, e, uso de um composto
ATE323088T1 (de) Bicyclische pyridin-und pyrimidinderivate als neuropeptid y rezeptorantagonisten
EA200101177A1 (ru) Производные индола в качестве антагонистов прогестерона
CY1105212T1 (el) Αντισωματα αντι-april και κυτταρα υβριδωματος
EP1461061A4 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von krankheiten und zuständen im zusammenhang mit chemokine-rezeptoren
EP1383919A4 (de) Verfahren und zusammensetzungen zur verwendung von mhc-klasse ii-invariante-kette-polypeptid als rezeptor für makrophagenwanderung-hemmfaktor
WO2009129311A3 (en) Somatostatin receptor 2 antagonists
ATE517125T1 (de) ANTIKÖRPER GEGEN ßDEATH RECEPTOR 4ß (DR4) UND DEREN VERWENDUNGEN
ATE390922T1 (de) 2-aminobenzothiazole als cb1 rezeptor inverse agonisten
ZA200508390B (en) Compositions and methods for the therapy of inflammatory bowel disease
ATE481103T1 (de) Derivate von 2-(8,9-dioxo-2,6- diazabicyclo(5.2.0)non-1(7)-en-2- yl)alkylphosphonsäure und deren verwendung als n- methyl-d-aspartat- (nmda-) rezeptorantagonisten
ATE356623T1 (de) 5-ht3-rezeptorantagonisten und verwendungsverfahren
ATE429421T1 (de) Arylindenopyridin- und arylindenopyrimidinverbindungen und ihre verwendung als adenosin-a2a-rezeptor antagonisten
EA200000198A1 (ru) 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов
DE60007841D1 (de) Neue azabicyclo derivate und ihre verwendung
DE60139770D1 (de) Hydantoin derivate mit affinität für somatostatin rezeptoren
DE60319989D1 (de) Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande
WO2003104395A3 (en) RECEPTORS AND PROTEINS ASSOCIATED WITH A MEMBRANE-
SE0303418D0 (sv) New use 1
SE0303488D0 (sv) New use 1X
BR0307814A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento de um distúrbio ou de uma doença e para tratamento de psicose em um mamìfero

Legal Events

Date Code Title Description
8364 No opposition during term of opposition